The impact of the ovarian microenvironment on the anti-tumor effect of SPARC on ovarian cancer<sup>1</sup>This article is part of Special Issue entitled Asilomar Chromatin and has undergone the Journal’s usual peer review process.

A lack of host-derived SPARC promotes disease progression in an intraperitoneal (IP) ID8 mouse model of epithelial ovarian cancer (EOC). Since orthotopic injection (OT) of ID8 cells better recapitulates high-grade serous cancer, we examined the impact of host-derived SPARC following OT injection. Sparc−/− and wild-type (WT) mice were injected with ID8 cells either OT or IP and tumors were analyzed at the moribund stage. Sparc−/− mice had reduced survival and fewer well-defined abdominal lesions compared with WT controls after IP injection, whereas no differences were observed in survival or abdominal lesions between Sparc−/− and WT mice after OT injection. No differences in mass or collagen content were observed in ovarian tumors between OT-injected Sparc−/− and WT mice. The abdominal wall of the IP-injected Sparc−/− mice exhibited immature and less abundant collagen fibrils compared with WT mice both in injected and non-injected controls. In contrast to human EOC, SPARC was expressed by the tumor cells but was absent in reactive stroma of WT mice. Exposure to the ovarian microenvironment through OT injections alters the metastatic behaviour of ID8 cells, which is not affected by the absence of host-derived SPARC.

The impact of the ovarian microenvironment on the anti-tumor effect of SPARC on ovarian cancer¹This article is part of Special Issue entitled Asilomar Chromatin and has undergone the Journal’s usual peer review process. Journal Articles